Home Tags Disease

disease Related Content

tackle kidney disease, japanese society of nephrology

The Japanese Society of Nephrology: Research and education to tackle kidney disease

Here we find out how The Japanese Society of Nephrology engages in research developing human resources, providing lifelong education and disseminating knowledge to the public, to tackle kidney disease and promote health.
healthy ageing

A focus on promoting healthy ageing in Hong Kong

Hong Kong’s Elderly Health Service has an increasingly important role to play in improving primary healthcare of the elderly, as this article discovers, with a special focus on recommended exercise as one of the many elements to promote healthy ageing in individuals.

Environmental exposures during early life influence adult disease risk

Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
your chemistry

Getting your chemistry right

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, at University of Strathclyde, explains the importance of getting your chemistry right.
regulation of hepatitis B

Multi-step regulation of hepatitis B virus entry

Koichi Watashi, Senior Researcher from the National Institute of Infectious Diseases, Japan, explores the trick for cell invasion in reaching regulation of hepatitis B entry.
viral hepatitis, world hepatitis day

The burden of viral hepatitis in the WHO Region of Africa

Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the WHO Region of Africa.
Mfa1 fimbriae, Porphyromonas gingivalis,

Periodontal disease: Structure of Mfa1 fimbriae

Professor Yoshiaki Hasegawa discusses the structure and biogenesis mechanism of Mfa1 fimbriae from the periodontal pathogen Porphyromonas gingivalis.
history of public health

The early history of public health from an evolutionary perspective

Romola Davenport and Richard Smith, Cambridge Group for the History of Population and Social Structure, Department of Geography, University of Cambridge, explore the history and evolution of public health, in this article.
Enzyme activity assays

Chemistry: Enzyme activity assays for disease diagnosis

Contributing scientists share their thoughts around the field of chemistry, focussing on enzyme activity assays for disease diagnosis, novel drug development validation and nanoparticles.
advances in plant pathology, tomato diseases

Advances in plant pathology: Impact on tomato diseases

Aarthi Janakiraman, Industry Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, discusses advances in plant pathology, with a focus on the impact of this on tomato diseases.
opportunities in dementia research, disease-modifying treatment

Current gaps and future opportunities in dementia research

Here, Hilary Evans, Chief Executive at Alzheimer’s Research UK, outlines the current gaps and future opportunities in dementia research.
vessel growth

Vessel growth in health and disease

John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
mitochondrial-lysosomal, diabetic retinopathy

The role of TXNIP in mitochondrial-lysosomal axis dysregulation

Lalit P. Singh, Associate Professor at Wayne State University School of Medicine, explains the role of TXNIP in mitochondrial-lysosomal axis dysregulation in diabetic retinopathy.
Diabetes in the African region, diabetes medication

The prevalence of diabetes in the African region

In this interview, Jean-Marie Dangou from the WHO Regional Office for Africa discusses diabetes in the African region, including lack of access to treatment and ongoing action to solve this.
cost-effectiveness

Precision medicine: Cost-effectiveness of breakthrough treatments

Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
europe's silent killer, waste seperation

Europe’s silent killer: The air we breathe

Monika Kosinska, Programme Manager, Governance for Health Division at the World Health Organization explains why the air we breathe is Europe’s silent killer.
crisis of maternal mortality, NICHD

Research needed to address the crisis of maternal mortality

Dr Diana W. Bianchi, Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), exposes the need to address maternal mortality.
visual impairment diseases, national eye institute

Research on visual impairment diseases by the U.S.

Here, Open Access Government explore how the National Eye Institute in the U.S is supporting vision research that encompasses visual impairment diseases of people of all ages.
global data sharing

Japan: Challenges around global data sharing for orphan diseases

Makoto Suematsu, President of the Japan Agency for Medical Research and Development (AMED) details the challenges around global data sharing for orphan diseases.
systematic lupus, chronic autoimmune condition

MASTERPLANS to disentangle Systemic Lupus Erythematosus (SLE)

Professor Ian N Bruce MD FRCP, Professor of Rheumatology at the University of Manchester shares his expertise here on Systemic Lupus Erythematosus (SLE), a chronic multisystem autoimmune condition.

Follow Open Access Government